GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (LTS:0MR5) » Definitions » E10

CellaVision AB (LTS:0MR5) E10 : kr4.77 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is CellaVision AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CellaVision AB's adjusted earnings per share data for the three months ended in Dec. 2024 was kr1.720. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr4.77 for the trailing ten years ended in Dec. 2024.

During the past 12 months, CellaVision AB's average E10 Growth Rate was 10.60% per year. During the past 3 years, the average E10 Growth Rate was 18.60% per year. During the past 5 years, the average E10 Growth Rate was 18.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of CellaVision AB was 22.10% per year. The lowest was 15.60% per year. And the median was 18.60% per year.

As of today (2025-03-24), CellaVision AB's current stock price is kr169.50. CellaVision AB's E10 for the quarter that ended in Dec. 2024 was kr4.77. CellaVision AB's Shiller PE Ratio of today is 35.53.

During the past 13 years, the highest Shiller PE Ratio of CellaVision AB was 184.21. The lowest was 30.10. And the median was 110.95.


CellaVision AB E10 Historical Data

The historical data trend for CellaVision AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB E10 Chart

CellaVision AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.39 2.85 3.85 4.26 4.77

CellaVision AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.26 4.44 4.57 4.51 4.77

Competitive Comparison of CellaVision AB's E10

For the Medical Devices subindustry, CellaVision AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Shiller PE Ratio falls into.



CellaVision AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CellaVision AB's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.72/132.9872*132.9872
=1.720

Current CPI (Dec. 2024) = 132.9872.

CellaVision AB Quarterly Data

per share eps CPI Adj_EPS
201503 0.340 99.950 0.452
201506 0.210 99.995 0.279
201509 1.020 100.228 1.353
201512 0.638 100.276 0.846
201603 0.420 100.751 0.554
201606 0.710 101.019 0.935
201609 0.640 101.138 0.842
201612 0.747 102.022 0.974
201703 1.060 102.022 1.382
201706 0.810 102.752 1.048
201709 0.320 103.279 0.412
201712 0.720 103.793 0.923
201803 0.800 103.962 1.023
201806 0.980 104.875 1.243
201809 0.700 105.679 0.881
201812 1.240 105.912 1.557
201903 1.150 105.886 1.444
201906 1.270 106.742 1.582
201909 0.720 107.214 0.893
201912 1.020 107.766 1.259
202003 0.850 106.563 1.061
202006 1.140 107.498 1.410
202009 0.560 107.635 0.692
202012 1.200 108.296 1.474
202103 1.190 108.360 1.460
202106 1.300 108.928 1.587
202109 1.090 110.338 1.314
202112 1.660 112.486 1.963
202203 1.610 114.825 1.865
202206 1.560 118.384 1.752
202209 0.440 122.296 0.478
202212 1.350 126.365 1.421
202303 0.810 127.042 0.848
202306 1.460 129.407 1.500
202309 1.090 130.224 1.113
202312 2.110 131.912 2.127
202403 1.260 132.205 1.267
202406 1.620 132.716 1.623
202409 1.300 132.304 1.307
202412 1.720 132.987 1.720

Add all the adjusted EPS together and divide 10 will get our e10.


CellaVision AB  (LTS:0MR5) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CellaVision AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=169.50/4.77
=35.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of CellaVision AB was 184.21. The lowest was 30.10. And the median was 110.95.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


CellaVision AB E10 Related Terms

Thank you for viewing the detailed overview of CellaVision AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.

CellaVision AB Headlines

No Headlines